# FDA recall Z-1043-2026

> **Medtronic Neuromodulation** · Class II · device recall initiated 2025-12-03.

## Product

A71200 Vanta" Clinician Programmer Application (CP App) version  2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).

## Reason for recall

Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.

## Distribution

Worldwide - US Nationwide distribution.

## Key facts

- **Recall number:** Z-1043-2026
- **Recalling firm:** Medtronic Neuromodulation
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2025-12-03
- **Report date:** 2026-01-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Minneapolis, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1043-2026

## Citation

> AI Analytics. FDA recall Z-1043-2026. Retrieved 2026-08-11 from https://api.ai-analytics.org/recall/Z-1043-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*